InvestorsHub Logo
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

Re: buckiii2 post# 23779

Wednesday, 11/01/2017 10:51:39 AM

Wednesday, November 01, 2017 10:51:39 AM

Post# of 23979
CATB. October 26, 2017 08:00 AM Eastern Daylight Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that CAT-5571, which restores host defense by activating autophagy, will be presented in a poster at the 31st Annual North American Cystic Fibrosis Conference (NACFC). NACFC is being held November 2 – November 4, 2017, in Indianapolis, IN, at the Indiana Convention Center.

A poster titled “CAT-5571 Improves the Clearance of Intracellular Burkholderia Cenocepacia from Primary Cystic Fibrosis Macrophages,” resulting from a collaboration between Catabasis and Dr. Amal Amer at Ohio State University, will be presented during Poster Session 1 on Thursday, November 2, 2017, from 11:15am – 1:45pm local time.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.